Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease?

被引:7
|
作者
Rizzoni, Damiano [1 ]
Agabiti-Rosei, Claudia [1 ,2 ]
Boari, Gianluca E. M. [3 ]
Muiesan, Maria Lorenza [1 ,2 ]
De Ciuceis, Carolina [1 ,2 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, I-25121 Brescia, Italy
[2] Spedali Civili Brescia, Div Med 2, I-25123 Brescia, Italy
[3] Spedali Civili Brescia, Div Med, I-25123 Brescia, Italy
关键词
microcirculation; peripheral circulation; remodeling; small resistance arteries; vascular biology; SMALL-ARTERY STRUCTURE; SMALL-RESISTANCE ARTERIES; TO-LUMEN RATIO; SUBCUTANEOUS SMALL ARTERIES; II-INDUCED HYPERTENSION; RETINAL ARTERIOLES; BLOOD-PRESSURE; MICROVASCULAR STRUCTURE; STRUCTURAL ALTERATIONS; OXIDATIVE STRESS;
D O I
10.3390/jcm12154892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Arterial hypertension is a common condition worldwide and an important risk factor for cardio- and cerebrovascular events, renal diseases, as well as microvascular eye diseases. Established hypertension leads to the chronic vasoconstriction of small arteries as well as to a decreased lumen diameter and the thickening of the arterial media or wall with a consequent increased media-to-lumen ratio (MLR) or wall-to-lumen ratio (WLR). This process, defined as vascular remodeling, was firstly demonstrated in small resistance arteries isolated from subcutaneous biopsies and measured by micromyography, and this is still considered the gold-standard method for the assessment of structural alterations in small resistance arteries; however, microvascular remodeling seems to represent a generalized phenomenon. An increased MLR may impair the organ flow reserve, playing a crucial role in the maintenance and, probably, also in the progressive worsening of hypertensive disease, as well as in the development of hypertension-mediated organ damage and related cardiovascular events, thus possessing a relevant prognostic relevance. New non-invasive techniques, such as scanning laser Doppler flowmetry or adaptive optics, are presently under development, focusing mainly on the evaluation of WLR in retinal arterioles; recently, also retinal microvascular WLR was demonstrated to have a prognostic impact in terms of cardio- and cerebrovascular events. A rarefaction of the capillary network has also been reported in hypertension, which may contribute to flow reduction in and impairment of oxygen delivery to different tissues. These microvascular alterations seem to represent an early step in hypertension-mediated organ damage since they might contribute to microvascular angina, stroke, and renal dysfunction. In addition, they can be markers useful in monitoring the beneficial effects of antihypertensive treatment. Additionally, conductance arteries may be affected by a remodeling process in hypertension, and an interrelationship is present in the structural changes in small and large conductance arteries. The review addresses the possible relations between structural microvascular alterations and hypertension-mediated organ damage, and their potential improvement with antihypertensive treatment.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Microcirculation in hypertension and cardiovascular disease
    Pries, Axel R.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2014, 16 (0A) : A28 - A29
  • [2] Evaluation of the microcirculation in hypertension and cardiovascular disease
    Struijker-Boudier, Harry A. J.
    Rosei, Agabiti E.
    Bruneval, Patrick
    Camici, Paolo G.
    Christ, Frank
    Henrion, Daniel
    Levy, Bernard I.
    Pries, Axel
    Vanoverschelde', Jean-Luc
    EUROPEAN HEART JOURNAL, 2007, 28 (23) : 2834 - 2840
  • [3] Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension
    Zhang, Ruifeng
    Shi, Liuhong
    Zhou, Lin
    Zhang, Gensheng
    Wu, Xiaohong
    Shao, Fangchun
    Ma, Guofeng
    Ying, Kejing
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2014, 306 (06) : L574 - L583
  • [4] Lipoprotein(a) as a therapeutic target in cardiovascular disease
    Koschinsky, Marlys
    Boffa, Michael
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (07) : 747 - 757
  • [5] INFLAMMATION AS A THERAPEUTIC TARGET IN CARDIOVASCULAR DISEASE
    Ritchie, R.
    CARDIOLOGY, 2015, 132 : 32 - 32
  • [6] Telomerase as a Therapeutic Target in Cardiovascular Disease
    Hoffmann, Jedrzej
    Richardson, Gavin
    Haendeler, Judith
    Altschmied, Joachim
    Andres, Vicente
    Spyridopoulos, Ioakim
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (03) : 1047 - 1061
  • [7] Autophagy as a therapeutic target in cardiovascular disease
    Nemchenko, Andriy
    Chiong, Mario
    Turer, Aslan
    Lavandero, Sergio
    Hill, Joseph A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (04) : 584 - 593
  • [8] CaMKII as a Therapeutic Target in Cardiovascular Disease
    Gaido, Oscar E. Reyes
    Nkashama, Lubika J.
    Schole, Kate L.
    Wang, Qinchuan
    Umapathi, Priya
    Mesubi, Olurotimi O.
    Konstantinidis, Klitos
    Luczak, Elizabeth D.
    Anderson, Mark E.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2023, 63 : 249 - 272
  • [9] Microbiota treatment: the future target to prevent cardiovascular disease?
    Mladenova, Irena
    PANMINERVA MEDICA, 2022, 64 (01) : 133 - 134
  • [10] Reducing salt intake to prevent hypertension and cardiovascular disease
    He, Feng J.
    Campbell, Norm R. C.
    MacGregor, Graham A.
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2012, 32 (04): : 293 - 300